Economic Evaluation of Hepatitis C Treatment Extension to Acute Infection and Early-Stage Fibrosis Among Patients Who Inject Drugs in Developing Countries: A Case of China

We aimed to assess the cost-effectiveness of (1) treating acute hepatitis C virus (HCV) vs. deferring treatment until the chronic phase and (2) treating all chronic patients vs. only those with advanced fibrosis; among Chinese genotype 1b treatment-naïve patients who injected drugs (PWID), using a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yin, Zhang, Hui, Zhang, Lei, Zou, Xia, Ling, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037788/
https://www.ncbi.nlm.nih.gov/pubmed/32012839
http://dx.doi.org/10.3390/ijerph17030800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037788/
https://www.ncbi.nlm.nih.gov/pubmed/32012839
http://dx.doi.org/10.3390/ijerph17030800

Ejemplares similares